Berlin, Germany

Orlin Petrov

USPTO Granted Patents = 24 


 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 1997-2017

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Orlin Petrov in Pharmaceutical Chemistry

Introduction

Orlin Petrov is a prominent inventor based in Berlin, Germany, known for his significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio consisting of 24 patents, Petrov has been at the forefront of developing novel compounds and processes that have the potential to address various medical challenges.

Latest Patents

Among Petrov's latest innovations is the patent titled "Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolines." This invention focuses on substituted phenoxypyridine compounds that present various applications in pharmaceutical compositions for treating hyper-proliferative and angiogenesis disorders. The patent outlines methods of preparing these compounds, along with their intermediates and combinations with other active ingredients.

Another notable patent is for a "Process for preparing epothilone derivatives by selective catalytic epoxidation." This innovative process utilizes substituted pyridines and methyltrioxorhenium as a catalyst, providing a novel approach towards synthesizing epothilone derivatives, which have implications in cancer treatment.

Career Highlights

Orlin Petrov's career includes significant tenures at leading pharmaceutical companies, such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His experiences in these companies have equipped him with extensive knowledge and expertise in developing innovative pharmaceutical solutions, enabling him to file and secure numerous patents throughout his career.

Collaborations

Throughout his career, Petrov has collaborated with notable coworkers, including Johannes Platzek and Jurgen Westermann. These partnerships have furthered his research capabilities, fostering an environment where innovative ideas can flourish and lead to impactful inventions in the pharmaceutical industry.

Conclusion

Orlin Petrov continues to be a key figure in the world of pharmaceutical innovations. His extensive work and patent contributions not only highlight his expertise but also demonstrate the potential of his inventions to address significant health conditions. Through both collaboration and innovation, Petrov is making strides in improving therapeutic options, showcasing the importance of research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…